The immune system's defense against cancer development depends on its ability to recognize cancer cells, so cancer cells have developed many ways to evade its normal surveillance functions. Immunotherapies to induce immune response include cytokines, monoclonal antibodies (mAbs), and cancer vaccines. Passive therapies that stimulate a patient's intrinsic immune response include bispecific T-cell engagers (BiTE Antibodies), bispecific and multispecific antibodies, oncolytic viruses, cell-based therapies, and tumor-targeting mAbs.
Learn more about “Inside Immunotherapy”, an augmented reality game that takes you through a research mission to develop a personalized immunotherapy to fight cancer.
Learn More